Singapore, May 14 -- BD (Becton, Dickinson and Company), a US-based medical technology company, has announced the global commercial launch of the world's first cell analyser featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments - with increased ease and throughput.

BD SpectralFX Technology maximises the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time, with optimal resolution and sensitivity, which is ideal for scientists pursuing novel biomarker discovery.

BD CellVi...